Previous Article | Next Article 
J Virol, May 1998, p. 3742-3750, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
An Array of Novel Murine Spleen Focus-Forming
Viruses That Activate the Erythropoietin Receptor
Esperanza
Gomez-Lucia,1,
Yu
Zhi,2
Melud
Nabavi,1
Weibin
Zhang,1
David
Kabat,1 and
Maureen E.
Hoatlin2,*
Department of
Biochemistry1 and
Division of Hematology
and Medical Oncology,2 Oregon Health
Sciences University, Portland, Oregon 97201-3098
Received 21 October 1997/Accepted 28 January 1998
 |
ABSTRACT |
The Friend spleen focus-forming virus (SFFV) env gene
encodes a 409-amino-acid glycoprotein with an apparent
Mr of 55,000 (gp55) that binds to
erythropoietin receptors (EpoR) to stimulate erythroblastosis. We
reported previously the in vivo selection during serial passages in
mice of several evolutionary intermediates that culminated in the
formation of a novel SFFV (M. E. Hoatlin, E. Gomez-Lucia, F. Lilly, J. H. Beckstead, and D. Kabat, J. Virol. 72:3602-3609, 1998). A mouse injected with a retroviral vector in the
presence of a nonpathogenic helper virus developed long-latency erythroblastosis, and subsequent viral passages resulted in more pathogenic isolates. The viruses taken from these mice converted an
erythropoietin-dependent cell line (BaF3/EpoR) into factor-independent derivatives. Western blot analysis of cell extracts with an antiserum that broadly reacts with murine retroviral envelope glycoproteins suggested that the spleen from the initial mouse with mild
erythoblastosis contained an array of viral components that were
capable of activating EpoR. DNA sequence analysis of the viral genomes
cloned from different factor-independent cell clones revealed
env genes with open reading frames encoding 644, 449, and
187 amino acids. All three env genes contained 3' regions
identical to that of SFFV, including a 6-bp duplication and a
single-base insertion that have been shown previously to be critical
for pathogenesis. However, the three env gene sequences did
not contain any polytropic sequences and were divergent in their 5'
regions, suggesting that they had originated by recombination and
partial deletions of endogenously inherited MuLV env
sequences. These results suggest that the requirements for EpoR
activation by SFFV-related viruses are dependent on sequences at the 3'
end of the env gene and not on the polytropic regions or on
the 585-base deletions that are common among the classical strains of
SFFV. Moreover, sequence analysis of the different recombinants and deletion mutants revealed that short direct and indirect repeat sequences frequently flanked the deletions that had occurred, suggesting a reverse transcriptase template jumping mechanism for this
rapid retroviral diversification.
 |
INTRODUCTION |
Friend virus is a complex of a
replication-competent murine leukemia virus (F-MuLV) and a
replication-defective spleen focus-forming virus (SFFV) (32,
40). The SFFV component encodes a gp55 membrane glycoprotein that
binds to erythropoietin receptors (EpoRs) to cause erythroblast
proliferation and splenomegaly in susceptible mice (13, 24,
42). The gp55 is inefficiently processed to cell surfaces as a
disulfide-bonded dimer, and it appears that these cell surface dimers
are necessary for activation of EpoR (4, 8, 11, 25). The
gp55 is a modified recombinant glycoprotein with domains that are
closely related to the envelope glycoproteins of endogenously inherited
polytropic MuLVs and ecotropic MuLVs (20). Specifically,
gp55 contains an amino-terminal polytropic domain, a proline-rich
linker, and a carboxyl-terminal region that is related to the Env
glycoproteins encoded by ecotropic host range MuLVs (1, 6, 11, 18,
36, 56). The env genes of pathogenic SFFVs have common
features including a 585-base deletion and a single-base insertion in
the ecotropic region that causes a translational frameshift and
premature termination of the encoded protein. These features occur in
all previously described SFFV isolates and are thought to be important
for pathogenesis (2, 55). Identical features occur in the
independently isolated Rausher SFFV (3).
Both the pathogenic activities and infectivities of
replication-competent murine retroviruses rely on the virion envelope glycoproteins, which are synthesized as gPr90 precursors that are
cleaved by partial proteolysis to form surface (SU) gp70 and transmembrane (TM) p15E subunits (26, 32, 50). SU is
involved in receptor binding, and thus in specifying host-range and
interference properties (10), whereas TM is partially
embedded in the cell membrane and contributes to membrane fusion and to
immunosuppression (5, 54, 55). Although gp55 is encoded by
the env gene of SFFV, it lacks the gp70/p15E cleavage site
and a cytoplasmic tail and is not incorporated into virions
(18).
Like the genomes of many retroviruses, the genome of SFFV
is highly variable (19). Thus, strains of Friend
SFFV passaged in different laboratories are distinct (1, 6, 32,
40, 50, 57). The genetic variability of retroviruses depends on the mutation rate per replication cycle, the number of replication cycles, and the selective advantage or disadvantage of the particular mutation (17, 58). The mutation rate in retroviruses is
higher than in some other viral systems due to an error-prone reverse transcriptase (19, 48). Retroviral reverse transcriptase is poorly processive owing to its need to switch templates at least twice
during normal replication (34). The low degree of
processivity is supported by numerous experiments in vitro using
purified enzyme (33). Moreover, the fact that the retroviral
RNA is packaged as a dimer increases the possibilities for
recombination (19). The major types of retroviral genetic
variations include base pair substitutions, frameshifts, deletions
(with or without insertions), and homologous and nonhomologous
recombinations (51).
This report describes the evolution of a group of MuLVs which arose
after the inoculation of 4- to 8-week-old NIH/Swiss mice with a
retroviral vector lacking an expressed env gene plus a nonpathogenic isolate of MuLV (30). Initially, a mouse
developed erythroblastosis after a long latency of several months.
Subsequent in vivo passages resulted in a shortened latency of disease
and culminated in formation of a novel SFFV that is closely similar to
previous SFFV isolates (15a). The evolutionary intermediates were isolated based on their abilities to convert an
erythropoietin (Epo)-dependent cell line, BaF3/EpoR (BER), to
factor-independent derivatives. Sequence analysis of the
evolutionary intermediates revealed several rearrangements, including
recombinations, deletions, and base pair substitutions. Certain
deletions and recombinations appear to occur frequently because of
flanking direct and indirect repeat sequences that occur in the viral
genomes. We found that the 585-base deletion common to all previously
isolated SFFVs is not necessary for pathogenesis but appears to be a
hotspot for deletions due to a flanking direct repeat sequence. Since the viruses that we analyzed were selected based on their abilities to
activate EpoR, their common features implicate specific glycoprotein sequences in activation of this receptor.
 |
MATERIALS AND METHODS |
Viruses and cells.
EpoR-encoding virions were used to infect
the interleukin-3 (IL-3)-dependent hematopoietic cell line BaF3
(29) to produce the BER cells used in this study as
previously described (14). BaF3 cells were grown in RPMI
1640 medium supplemented with 10% fetal bovine serum and 5 × 10
5 M
-mercaptoethanol with 10% WEHI-3 conditioned
medium as a source of IL-3. BER cells were maintained in the same
medium with Epo (Boehringer Mannheim, Indianapolis, Ind.) at 0.5 U/ml
instead of IL-3. Preparation of passaged virus from spleens was
described previously (16).
Pathogenic assays.
Female NIH/Swiss mice (4 to 8 weeks old)
were inoculated with virus encoding wild-type EpoR mixed with ecotropic
helper virus B4 (30) as described previously
(16). Passaged virus was prepared from the enlarged spleens
of the diseased animals and was used immediately or frozen (
80°C).
The cell-free spleen homogenate was inoculated into other mice as first
passage or from these into other mice as second passage. Subsequent
passages were performed similarly. For factor-independent growth
assays, BaF3 cells or BER cells were exposed to the spleen filtrates
for 2 h at 37°C in the presence of Polybrene (8 mg/ml). The
cells were pelleted by centrifugation and resuspended in medium
containing growth factor for 48 h. The cells were then sedimented
by centrifugation, washed twice with phosphate-buffered saline, and
resuspended in complete medium without growth factors to allow for
selection of factor-independent cells. Some of the factor-independent
BER cells infected with the virus were cloned by limiting dilution (32) to obtain approximately 30 clones/96-well plate.
Western blots.
For Western blotting, cell lysates were
immunoprecipitated with an anti-F-MuLV gp70 antiserum that has broad
reactivity with MuLV Env glycoproteins (11, 43, 44) and
electrophoresed on polyacrylamide gels under reducing conditions in the
presence of 1% sodium dodecyl sulfate. The proteins were then
transferred to nitrocellulose membranes, immunoblotted with the same
antibody, and detected with [125I]protein A as described
previously (11, 23) or by using the Renaissance system (NEN,
Boston, Mass.).
Genomic studies.
Total RNA was extracted from cells or
spleens by standard methods. The DNA sequence of the viral genes was
obtained by reverse transcription-PCR (RT-PCR) as described in the
accompanying report (15a). Briefly, cDNA was made from total
cellular RNA by standard methods, and PCR was performed with either
Elongase (Gibco BRL) or PCR Supermix (Gibco BRL), using combinations of
the following primers. Sequences for the two forward primers were based
on homology to known MuLVs: U5 (5'-TCAGCGGGGGTCTTTCATTTG-3'),
located in the 5' long terminal repeat (LTR) (38); and
SF1 (5'-CGCAACCCTGGGAGACGTCC-3'), which overlaps the
retroviral packaging signal (10). The reverse primers were
U3 (5'-ACAGGTGGGGTCTTTCATTCC-3') (38) and PV3
(5'-CGTTACAGCGGCATCAGGCTAAGC-3'), both located within the 3'
LTR.
PCR products were TA cloned into the pCR 2.1 vector (Invitrogen),
sequenced, and compared to entries in sequence databases with the BLAST
algorithm. Multiple sequence alignments were done with the Clustal W
tool from the MacVector sequence analysis program (Oxford Molecular
Group, Ltd.).
Nucleotide sequence accession numbers.
The accession
numbers for the EE449, EE187, EE644, and DE410 sequences are
AF030174, AF030175, AF030173, and AF030182, respectively. The
GenBank accession numbers for sequences used to determine the
recombination sites are M93134, M10100, Z11128, V01552, J02193,
K00021, K02375, M93134, K02725, and Z22761.
 |
RESULTS |
An assortment of Env glycoproteins in factor-independent BER
cells.
In the accompanying report (15a), we described
the genesis of a new erythroleukemia virus that formed after mice were
injected with a nonpathogenic helper virus plus a pSFF-based retroviral vector that lacked a functional env gene (3).
Initially, a mouse developed erythroblastosis after a long latency, but
subsequent passages in mice yielded more rapid erythroblastosis and
polycythemia that culminated in the formation of a new SFFV. At
intermediate stages in the passaging, viruses that enabled BER cells to
survive and proliferate in the absence of growth factors were isolated. These viruses had no effect on the growth factor dependency of the
parental BaF3 cells, suggesting that the mitogenic effect was mediated
by EpoR. Interestingly, these virus isolates encoded SFFV-related Env
glycoproteins. A flow chart of the relationships between the infected
mice, BER cell clones, and virus nomenclature is shown in Fig.
1.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 1.
Relationships among animals, cell lines, and viruses
used in this study. The in vivo and in vitro passage histories of the
viruses described in this report are indicated with the terminology for
animals, BER cell lines, and viruses (boxed). The origin and
terminology for the cells and the corresponding viruses are described
in the text. The viruses are named according to the characteristics of
the envelope glycoproteins (EE, ecotropic amino-terminal domain and
ecotropic carboxyl-terminal domain; DE, dualtropic [or polytropic]
amino-terminal domain and ecotropic carboxyl-terminal domain). The
sequence from the 1129 spleen is a novel SFFV (DE410) and is described
in the accompanying report (15a). d, days.
|
|
The population of factor-independent BER cells derived from mouse 1218 (BER/1218) was used to isolate single-cell clones by
limiting dilution.
An immunoblot of Env glycoproteins in 11 of
the resulting cell clones
is shown in Fig.
2 (lanes 3 to 13).
In
comparison with BER cells infected with wild-type SFFV (lane
1) or with
the uncloned population of BER cells infected with
the 1218 virus (lane
2), all of the cell clones contained a slowly
migrating component with
an apparent
Mr of ~90,000 which occurs
endogenously in the BaF3 cell line (
14) in addition to novel
components. The results suggest that the early-passaged 1218 virus
that
was used to infect the BER cells contained at least three
different
viruses that were able to activate EpoR. The most abundant
of these
viruses encoded an
Mr-60,000 glycoprotein that
was present
in the majority of the factor-independent cell clones,
whereas
a gp55-encoding virus was evidently present in one cell clone
(lane 6). One of the factor-independent cell clones appeared to
lack
both gp60 and gp55 glycoproteins and to contain additional
components
with sizes expected for the gPr90 and gp70 glycoproteins,
consistent
with what would be encoded by a replication-competent
helper virus
(lane 11). In addition, several of the lanes (including
lane 11)
contained traces of smaller glycoproteins that we initially
presumed
were breakdown products of the components shown in Fig.
2.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
Env glycoproteins in growth factor-independent clones of
BER cells infected with passaged virus. Lysates from BER cells infected
with wild-type SFFV (lane 1), BER cells infected with passaged virus
1218 (from which 11 clones analyzed in this blot were obtained by
limiting dilution) (lane 2), clone 5S (lane 3), clone 4S (lane 4),
clone 3S (lane 5), clone 2S (lane 6), clone 1S (lane 7), clone 6F (lane
8), clone 5F (lane 9), clone 4F (lane 10), clone 3F (lane 11), clone 2F
(lane 12), and clone 1F (lane 13) were immunoprecipitated with anti-Env
antibody, run on electrophoresis gels under reducing conditions, and
transferred to nitrocellulose membranes. The membranes were again
incubated with anti-Env antibody and then with
[125I]protein A. The higher-Mr
band at 70,000 to 90,000 occurs endogenously in the BaF3 cells
(14).
|
|
env sequences of the novel viruses.
To determine
the viral sequences present in infected BER factor-independent cells,
RT-PCR was performed on total RNA isolated from BER/1218 clones 2F and
3F (Fig. 2, lanes 11 and 12) and from BER cells that were infected with
a later passage of the 1218 virus (termed BER/1129) as well as with
control factor-dependent cells. Amplified products that were
reproducibly observed and unique to the factor-independent cells were
cloned and sequenced (see Materials and Methods). The DNA sequences
obtained are shown in Fig. 3 in
comparison to an ecotropic env gene with the closest homology to the viral sequences. The 3' regions of the env
genes analyzed in this work were all identical to each other and with those remaining in the pSFF vector (pSFF GenBank accession no. Z22761),
suggesting that the pSFF vector was a common source in the
recombinations that we observed. Although these 3' env sequences remain in pSFF, there is a large deletion in 5' sequences that eliminates the initiation codon and the pSFF vector consequently does not encode any Env glycoprotein. All of the novel sequences contained several characteristic hallmarks of an SFFV, such as (i) a
single-base insertion that causes a frameshift mutation and leads to a
premature termination of the encoded protein and (ii) a six-base
duplication. EE449 and EE187 also contained the 585-base deletion (the
positions of these features are indicated in Fig. 3). However, as shown
in Fig. 3, the 5' regions of the EE644, EE449, and EE187 sequences were
closely related to the ecotropic MuLV reference sequence shown on line
1. Based on extensive sequence comparisons with many related viral
env sequences (see the legend to Fig. 3 for sequences used
in the comparison), we propose that the novel viruses formed by
recombinations of the pSFF vector with ecotropic env
sequences that were present in the mice. The likely recombination sites
are boxed in Fig. 3. The recombination sites are difficult to identify
because there is homology among ecotropic and polytropic sequences in
several regions. However, because we found that the 3' sequences of the novel viruses were nearly identical to the 3' sequence of the pSFF
vector, a divergence in the nucleotide substitutions indicated that a
recombination had occurred. The figure also shows the partial sequence
of the 585 bases that are deleted in SFFVs and in EE449 and EE187. This
585-base sequence occurs in EE644 and is flanked by a short direct
repeat (Fig. 3 and 5).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Nucleotide sequences of the novel env genes.
The sequences are compared to an ecotropic env sequence (GenBank
accession no. Z11128) shown on line 1. Nucleotides for EE644 (line 2),
EE449 (line 3), and EE187 (line 4) are shown where the sequences differ
from the reference sequence. Sequences flanking deletions are shown,
and repeated bases are underlined. Lowercase letters represent
sequences proposed to have participated in the deletion and are not
present in the final viral sequence. Proposed recombination sites for
the viral sequences are shown on lines 2, 3, and 4 and are boxed and
labeled. Sequences of EE187, EE449, and EE644 are identical to the pSFF
vector sequence after the recombination site proposed for EE644. The
786-nucleotide in-frame deletion in EE187 is indicated by arrows. The
585 bases deleted in EE449 and EE187 (lines 2 and 3, respectively) but
present in the reference sequence and EE644 are bracketed (lines 1 and
2, respectively). The sites of the 6-base duplication
( 6) and single-base insertion ( 1) are
indicated by inverted triangles. A series of dots indicates where
additional sequence exists but is not shown.
|
|
Figure
4 shows the
amino acid sequences of the Env glycoproteins in the viral isolates in
comparison to each other and to
the novel SFFV DE410, the gp55 sequence
that ultimately formed
in the mice. The DE410 SFFV sequence is shown in
Fig.
4 as a reference
because it contains the classical features of
SFFV gp55s, including
a polytropic-related sequence in the amino
terminus and an ecotropic-related
sequence in the carboxyl-terminal
region. As shown, the DE410
amino acid sequence is very similar to the
ecotropic envelope
sequences at the carboxyl-terminal region, and it
deviates dramatically
from EE644, EE449, and EE187 sequences in the
amino-terminal region.
Thus, the latter Env glycoproteins have
amino-terminal regions
very different from those of gp55s.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 4.
Retrovirus-related env sequences present in
factor-independent BER cells. The envelope glycoproteins are encoded by
the sequences obtained from the BER factor-independent cells (EE449,
EE187, and EE644) and an enlarged spleen from an animal injected with a
highly passaged virus preparation (DE410). Five amino-terminal residues
common to the novel env sequences are underlined. Amino acid identities
are shaded, nonconservative substitutions are shown without shading,
and conservative substitutions are boxed. Deletions are indicated by
dashes. SFFV characteristics and viral protein landmarks are numbered
as follows: 1, the 786-nucleotide (262-amino-acid) in-frame deletion in
EE187; 2, the proline-rich region; 3, the site of the 585-base in-frame
deletion that eliminates the gp70/p15E cleavage site in SFFVs and in
EE449 and EE187; 4, the gp70/p15E cleavage site in MuLVs which is
eliminated in SFFVs; 5, insertion of two leucines caused by a 6-base
duplication; 6, site of the single-base insertion causing early
termination. Proposed recombination sites are indicated by asterisks
and labeled.
|
|
The EE449 sequence indicated an open reading frame encoding 449 residues with a predicted
Mr of 49,000. Because
several potential
N-glycosylation sites are present in the deduced
amino acid sequence,
the calculated
Mr is
compatible with the observed
Mr of 60,000
for
the glycoprotein in the BER/1218/2F cells. In comparison,
most strains
of SFFV encode glycoproteins of 409 amino acids and
an observed
Mr of 55,000.
The EE187 sequence contained an open reading frame predicted to encode
187 amino acids. Like the Env encoded by EE449, the
sequence of EE187
has overall homology to ecotropic Envs and lacks
the polytropic
amino-terminal region found in DE410 and other
SFFVs. An
Mr of 20,500 is predicted for the unglycosylated
EE187
Env glycoprotein. It is difficult to determine with confidence
whether this protein is present on Western blots of BER/1218/3F
lysates
(Fig.
2, lane 11). Many weak bands are present in this
size range and
could possibly be proteolytic products of larger
Env glycoproteins.
Moreover, since EE187 has two large deletions,
the polyclonal antibody
used in the immunoblot in Fig.
2 may not
have recognized the EE187
glycoprotein. Since the EE187 sequence
was reproducibly isolated, we
conclude that it was present in
the BER/1218/2F cells.
The EE644 virus was isolated in a clone of BER cells (BER/1129) that
became factor independent after infection with a virus
from a spleen
extract. This same mouse spleen also contained the
DE410 virus as shown
in Fig.
1. The EE644 sequence encodes a predicted
Env protein of 644 amino acids (Fig.
4), starting with the characteristic
MACSTL... of
ecotropic viruses. Since the deduced sequence includes
the gp70/p15E
cleavage site, the EE644 Env glycoprotein would
be expected to encode a
gp70 glycoprotein similar to that of the
helper virus used in these
experiments. This prediction was confirmed
by Western blotting (data
not shown). However, the p15E region
of the EE644 glycoprotein is
truncated in a manner identical to
the carboxyl-terminal region of
gp55.
Total RNA extracted from the spleen of a mouse injected with a highly
passaged virus was also sequenced. The sequence DE410,
discussed in the
accompanying report (
15a), is predicted to encode
a
410-amino-acid glycoprotein for a new SFFV. As reported previously,
sequence landmarks in the DE410 glycoprotein are consistent with
a
recombination between ecotropic sequences and endogenous polytropic
sequences (this recombination site is indicated in Fig.
3), which
resulted in a sequence typical for SFFVs.
Nucleotide sequences flanking the observed deletions.
During
the course of this investigation, nucleotide sequences were cloned not
only from the env gene regions but also from the
gag-pol regions of the retroviral sequences. In many
cases, the clones contained deletions in comparison to reference
sequences in the databases or in comparison with other clones that we
isolated. Interestingly, these deletions (including the 585-base
deletion that is common to SFFVs) were frequently flanked either by
short direct repeats or by inverted repeats in the reference sequences. The sequences that we isolated were all deposited in GenBank (accession numbers are listed in Materials and Methods). Figure
5 shows a compilation of the types of
deletions and flanking sequences that we observed.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Deletions observed in viral sequences are flanked by
direct (A) or indirect (B) repeat sequences. DNA sequences were
determined by dideoxy sequencing from the cloned RT-PCR products from
BER factor-independent cell lines or enlarged spleens as indicated and
as described in the text. Details of two different types of deletions
are shown at the deletion junction with flanking sequence. The repeated
sequences are boxed. nts, nucleotides.
|
|
 |
DISCUSSION |
Requirements for EpoR stimulation and pathogenicity by retroviral
envs related to SFFV.
MuLVs produce a variety of
progressive hematopoietic disorders, including erythroleukemias
(7, 18, 41, 50). The pathogenic activity of the
replication-defective SFFVs is mediated by the binding of the
SFFV-encoded gp55 glycoprotein to EpoR in the erythroblasts (24), and this triggers cell proliferation that will
eventually lead to erythroleukemia (9). The gp55
glycoprotein is processed to cell surfaces as a disulfide-bonded dimer,
and this dimeric structure on cell surfaces is required for activation
of EpoR (4, 8, 11, 12, 25). Several of the characteristics that distinguish gp55s from the envelope glycoproteins of MuLVs have
been previously implicated in the induction of erythroblastosis: a
polytropic amino-terminal region, a 585-base deletion, a 6-base duplication, and a single-base insertion, as described above. These modifications have been proposed to be important based on their occurrence in the sequences of different strains of SFFV and on
experiments designed to test each modification separately for its
contribution to pathogenicity (2, 5, 27, 47, 54, 55, 59),
although the role of polytropic amino-terminal sequences in activation
of EpoR and in SFFV pathogenesis has been uncertain (46,
54). The common occurrence of the identical 585-base
(195-amino-acid) deletion in natural SFFVs, including the independently
isolated Friend and Rausher SFFVs, has been confusing because expanded
deletions in this region do not reduce pathogenesis. Indeed, these
deletions substantially enhance pathogenicity in mice homozygous for
the Fv-2r resistance allele (15, 28).
The surprising result that we report here is that although the BER
cells infected with virus from mouse 1129 or 1218 became factor
independent, and this correlated with the detection of Env
glycoproteins on Western blots, these Env glycoproteins did not include
all four of the SFFV characteristic features that were common to
previously analyzed gp55s. For example, EE644 contains the 6-base
duplication and the single-base insertion but has an ecotropic
amino-terminal region and no 585-base deletion. Similarly, EE449 and
EE187 have the 6-base duplication, the single-base insertion, and the
585-base deletion but also contain an ecotropic amino-terminal region
and lack any polytropic sequences. By characterizing and comparing
env sequences able to activate EpoR, a profile of minimal
required sequences for receptor activation may emerge. For example, in
addition to the striking carboxyl-terminal similarities observed, the
novel sequences contain a five-amino-acid identity in the
amino-terminal region (Fig. 4, positions 40 to 45).
A strength of this work was our ability to detect viral intermediates
in a process of SFFV evolution in vivo and to clonally
isolate these
intermediates based on their abilities to activate
EpoR in BER cells.
This enabled us to isolate and to study viruses
that were only weakly
pathogenic in the mice and that presumably
contributed to the observed
erythroblastosis and to the process
of SFFV evolution. The fact that
all of our virus isolates encoded
in-frame Env glycoproteins that were
absent from the Epo-dependent
BaF3/EpoR cells but present in the
factor-independent derivatives
strongly supports our conclusion that
they were able to activate
EpoR and that they contributed to the
erythroid cell proliferation
in these mice. The parental BaF3/EpoR
cells are strictly dependent
on either IL-3 or Epo for survival and
growth. It should be emphasized
that the individual Env-encoding
viruses that we have identified
were obtained from mice that had
erythroproliferative disease
and contained a swarm of distinct viral
components. It is difficult
in this circumstance to precisely trace the
evolutionary lineages
of the individual viruses or to unambiguously
know their pathogenic
characteristics. Studies to reconstitute the
molecularly cloned
env sequences into proviral structures and test
their individual
roles in pathogenesis are in progress.
Recombination with nonpathogenic input vector sequences resulted in
novel viruses.
Of the three types of recombinations previously
described by Zhang and Temin (58), we have observed only the
general type, in which the sequences used as a vector recombined
with endogenous polytropic and ecotropic sequences upstream of the 3'
LTR. Little sequence identity (<7 nucleotides) is needed for such
recombination events to occur (49), and since ecotropic
sequences remaining in the vector are similar to the ecotropic
helper virus sequences, homologous recombinations could occur. It is
believed that reverse transcriptase jumps between templates at least
twice during normal replication (33) and that such template
switches may also occur during recombinations and deletions. Reverse
transcriptases lack editing functions and have been shown to be error
prone in vitro and therefore are presumed to contribute to the high
mutation rate in vivo (19).
We conclude that a recombination took place in the first three mice
that became sick. Virus was prepared and was further passed
to
other mice, and from one of these mice (1218) it was passed
to BER
cells (BER/1218) or to other mice (e.g., 1129). The sequences
isolated from the BER/1218 cells (EE449 and EE187) confirmed that
a recombination had taken place within a short sequence 36 bp
downstream of the 3' end of the proline-rich region between the
input
vector and ecotropic sequences, most probably with the ecotropic
B4
helper virus used in these experiments. Further passages also
led to
recombination near this site, resulting in EE644 and DE410.
Thus, all
of these recombinations probably occurred within a 160-bp
area just
downstream of the proline-rich region in SFFV (Fig.
3).
Purcell and others have reported a complex and related group of viral
elements that apparently formed by recombination in
a murine retroviral
packaging cell line and were transmitted to
rhesus macaques during
subsequent gene transfer experiments (
38).
Some of the
sequences isolated were highly related to polytropic
virus
env sequences, suggesting that complex and interrelated
retroviral recombinants may form from input sequences and endogenous
sequences. As the Purcell study and this report show, the use
of RT-PCR
and universal primers may allow the true complexity,
frequency, and
biological consequences of these events to be identified.
The deletions observed suggest a general mechanism for MuLV
diversification.
As previously proposed, deletions involving
two direct repeats presumably occur when reverse transcriptase copies
the first of the direct repeats and the growing DNA strand misaligns
with the homologous direct repeat found downstream in the template (31, 34, 35, 37, 52). This mechanism results in the deletion
of intervening sequences together with one of the repeats. In addition
to the deletions shown in Fig. 5, we observed three other deletions of
this category in the sequence of DE410 upstream of env (data not
shown). We also observed one deletion involving nonhomologous sequences
or sequences with very little similarity (data not shown). These latter
deletions confirm that reverse transcriptase is able to successfully
transfer between templates that have little or no sequence similarity.
Deletions of sequences flanked by divergent sequences with only 1 bp in
common have been observed in other retroviruses (33, 37, 45, 52,
53). Repeat-mediated deletions are not restricted to retroviral
replication since similar deletions have been observed in human genetic
diseases (21, 22, 39).
In addition to the 585-base deletion that is common in SFFV
envs, another large deletion, which eliminated a large
portion
of the amino-terminal region and most of the proline-rich
region
of the viral sequence, was observed in EE187. This deletion is
unusual because it is flanked by inverted repeats, which to our
knowledge have not been reported earlier. Inverted repeat-mediated
deletions are not obvious unless antecedent sequences are examined,
since both flanking repeats are absent from the final sequence.
Common
to all deletions observed in the viral sequences that we
report here is
that the number of bases deleted is always a multiple
of 3, emphasizing
the functional importance of keeping the sequence
in frame for
retroviral diversification to have biological consequences.
Unless a
virus mutant or recombinant can stimulate mitosis, the
virus sequence
would be expected to be eliminated by dilution,
because
nonproliferating cells produce relatively few retrovirions.
These
results support our conclusion that the envelope glycoproteins
of the
viruses that we cloned were under selective pressure in
vivo and had
pathogenic effects.
Besides recombinations and deletions, base substitutions were also
observed in the viruses. The same substitutions were not
in the
parental sequences but have been previously observed in
similar
viruses. It is uncertain whether these substitutions contributed
to
pathogenesis.
One interesting implication of our results is that the 585-base
deletion observed in the
env genes of all previously
isolated
SFFVs may be a consequence of an inherent instability of
this
sequence and not necessarily due to selective pressure to produce
EpoR stimulation. This 585-base deletion is flanked in the progenitor
viruses by a direct repeat sequence (Fig.
3). These observations
suggest that certain genes prone to repeat-mediated deletions
(e.g.,
Fanconi anemia group A and BRCA1) (
22,
39) may be
unstable
when expressed in retroviral vectors for gene therapy
applications.
Molecular evolution of an SFFV.
We have described an array of
viruses capable of activating EpoR that emerged as a result of in vivo
selection. Between 60 and 80 days postinfection, three mice displayed
massive splenomegaly and polycythemia. The spleen homogenates prepared
from the enlarged spleen of one mouse caused fulminant disease in all
subsequently infected mice. The viruses present in these mice enabled
Epo-dependent BER cells to become Epo independent. The viruses
characterized from the mice or from the factor-independent BER cells
contained recombinations as well as deletions and base pair
substitutions. Based on the relationships of the sequences, and their
temporal appearance, we propose that the EE449 and EE187 viruses may
have formed during the initial stages of infection and that these
and/or related variants caused a slowly developing erythroblastosis. The gp60 glycoprotein was prominent in the initial spleens, implying that the EE449 virus was abundant and that it was highly amplified in
that mouse. During subsequent viral passages, further viral evolution
that culminated in production of the novel DE410 isolate of SFFV
occurred. Our results demonstrate that the intermediate stages of this
retroviral evolution can be trapped in indicator cell lines (e.g., BER)
that have requirements for specific growth factors such as Epo.
Although such weakly pathogenic retroviruses have not been previously
studied and cannot be stably passaged in vivo, they are clearly capable
of causing serious indolent disease in individual animals.
 |
ACKNOWLEDGMENTS |
We are grateful to our colleagues Susan Kozak and Kirsten Silvey
for assistance and help in preparation of the manuscript.
This research was supported by grant CA54149 from the U.S. National
Institutes of Health and a grant from the Spanish Ministry of Science
and Education.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Hematology and Medical Oncology, Oregon Health Sciences University,
3181 S.W. Sam Jackson Park Rd., Mailcode L586, Portland, OR 97201. Phone: (503) 494-1123. Fax: (503) 494-6197. E-mail:
hoatlinm{at}OHSU.edu.
Present address: Departamento Patología Animal I, Facultad
de Veterinaria, Universidad Complutense, 28040 Madrid, Spain.
 |
REFERENCES |
| 1.
|
Amanuma, H.,
A. Katori,
M. Obata,
N. Sagata, and Y. Ikawa.
1983.
Complete nucleotide sequence of the gene for the specific glycoprotein (gp55) of spleen focus-forming virus.
Proc. Natl. Acad. Sci. USA
80:3913-3917[Abstract/Free Full Text].
|
| 2.
|
Amanuma, H.,
M. Watanabe,
M. Nishi, and Y. Ikawa.
1989.
Requirement of the single base pair insertion at the 3' end of the env related gene of Friend spleen-focus forming virus for pathogenic activity and its effect on localization of the glycoprotein product (gp55).
J. Virol.
63:4824-4833[Abstract/Free Full Text].
|
| 3.
|
Bestwick, R.,
B. Boswell, and D. Kabat.
1983.
Molecular cloning of biologically active Rauscher spleen focus-forming virus and the sequence of the long terminal repeat.
J. Virol.
51:695-705.
|
| 4.
|
Casadevall, N.,
C. LaCombe,
O. Muller,
S. Gisselbrecht, and P. Mayeux.
1991.
Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Cross-linking of erythropoietin with the spleen focus-forming virus envelope protein.
J. Biol. Chem.
266:16015-16020[Abstract/Free Full Text].
|
| 5.
|
Chung, S.,
L. Wolff, and S. Ruscetti.
1989.
Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth.
Proc. Natl. Acad. Sci. USA
86:7957-7960[Abstract/Free Full Text].
|
| 6.
|
Clark, S., and T. Mak.
1983.
Complete nucleotide sequence of an infectious clone of spleen focus-forming provirus: gp55 is an envelope fusion glycoprotein.
Proc. Natl. Acad. Sci. USA
80:5037-5041[Abstract/Free Full Text].
|
| 7.
|
Famulari, N. G.
1983.
Murine leukemia viruses with recombinant env genes: discussion of their role in leukemogenesis.
Curr. Top. Microbiol. Immunol.
103:75-108[Medline].
|
| 8.
|
Ferro, F.,
S. Kozak,
M. Hoatlin, and D. Kabat.
1993.
Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus.
J. Biol. Chem.
268:5741-5747[Abstract/Free Full Text].
|
| 9.
|
Friend, C.
1957.
Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia.
J. Exp. Med.
105:307-318[Abstract].
|
| 10.
|
Gerard, C.,
M. Arboleda,
G. Solar,
J. Mule, and W. Kerr.
1996.
A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses.
Hum. Gene Ther.
7:343-354[Medline].
|
| 11.
|
Gliniak, B., and D. Kabat.
1989.
Leukemogenic membrane glycoprotein encoded by Friend spleen focus-forming virus: transport to cell surfaces and shedding are controlled by disulfide-bonded dimerization and by cleavage of a hydrophobic membrane anchor.
J. Virol.
63:3561-3568[Abstract/Free Full Text].
|
| 12.
|
Gliniak, B.,
S. L. Kozak,
R. T. Jones, and D. Kabat.
1991.
Disulfide bonding controls processing of retroviral envelope glycoproteins.
J. Biol. Chem.
266:22991-22997[Abstract/Free Full Text].
|
| 13.
|
Hankins, D. W., and D. Troxler.
1980.
Polycythemia- and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro.
Cell
22:693-699[Medline].
|
| 14.
|
Hoatlin, M. E.,
F. E. Ferro,
R. W. Geib,
M. T. Fox,
S. L. Kozak, and D. Kabat.
1995.
Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host-range restrictions for erythroleukemia.
J. Virol.
69:856-863[Abstract].
|
| 15.
|
Hoatlin, M. E.,
F. E. Ferro, Jr.,
S. L. Kozak, and D. Kabat.
1994.
A Friend virus mutant encodes a small glycoprotein that causes erythroleukemia.
J. Virol.
68:4053-4056[Abstract/Free Full Text].
|
| 15a.
|
Hoatlin, M. E.,
E. Gomez-Lucia,
F. Lilly,
J. H. Beckstead, and D. Kabat.
1998.
Origin and rapid evolution of a novel murine erythroleukemia virus of the spleen focus-forming virus family.
J. Virol.
72:3602-3609[Abstract/Free Full Text].
|
| 16.
|
Hoatlin, M. E.,
S. L. Kozak,
F. Lilly,
A. Chakraborti,
C. A. Kozak, and D. Kabat.
1990.
Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene.
Proc. Natl. Acad. Sci. USA
87:9985-9989[Abstract/Free Full Text].
|
| 17.
|
Hu, W. S., and H. Temin.
1990.
Genetic consequences of packaging two RNA genomes in one retroviral particle:pseudo-diploidy and a high rate of genetic recombination.
Proc. Natl. Acad. Sci. USA
87:1556-1560[Abstract/Free Full Text].
|
| 18.
|
Kabat, D.
1989.
Molecular biology of Friend viral erythroleukemia.
Curr. Top. Microbiol. Immunol.
148:1-42[Medline].
|
| 19.
|
Katz, R., and A. Skalka.
1990.
Generation of diversity in retroviruses.
Annu. Rev. Genet.
24:409-405[Medline].
|
| 20.
|
Koch, W.,
W. Zimmerman,
A. Oliff, and R. Friedrich.
1984.
Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: implications for the function of these sequences.
J. Virol.
49:828-840[Abstract/Free Full Text].
|
| 21.
|
Krawczak, M., and D. Cooper.
1991.
Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.
Hum. Genet.
86:425-441[Medline].
|
| 22.
|
Levran, O.,
T. Erlich,
N. Mgdalena,
G. J, S. Batish,
P. Verlander, and A. Auerbach.
1997.
Sequence variation in the Fanconi anemia gene FAA.
Proc. Natl. Acad. Sci. USA
94:13051-13056[Abstract/Free Full Text].
|
| 23.
|
Li, J.-P.,
R. K. Bestwick,
C. Spiro, and D. Kabat.
1987.
The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor.
J. Virol.
61:2782-2792[Abstract/Free Full Text].
|
| 24.
|
Li, J.-P.,
A. D. D'Andrea,
H. F. Lodish, and D. Baltimore.
1990.
Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
Nature
343:762-764[Medline].
|
| 25.
|
Li, J. P.,
H. O. Hu,
Q. T. Niu, and C. Fang.
1995.
Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55.
J. Virol.
69:1714-1719[Abstract].
|
| 26.
|
Lilly, F.
1970.
Fv-2: identification and location of a second gene governing the spleen focus response of Friend leukemia virus in mice.
J. Natl. Cancer Inst.
45:163-169.
|
| 27.
|
Machida, C.,
R. Bestwick, and D. Kabat.
1985.
A weakly pathogenic spleen focus-forming virus that lacks the carboxy-terminal membrane anchor of its envelope glycoprotein.
J. Virol.
53:990-993[Abstract/Free Full Text].
|
| 28.
|
Majumdar, M. K.,
C.-L. Cho,
M. T. Fox,
K. L. Eckner,
S. L. Kozak,
D. Kabat, and R. W. Geib.
1992.
Mutations in the env gene of Friend spleen focus-forming virus overcome Fv-2r-mediated resistance to Friend virus-induced erythroleukemia.
J. Virol.
66:3652-3660[Abstract/Free Full Text].
|
| 29.
|
Mathey-Prevot, B.,
G. Nabel,
R. Palacios, and D. Baltimore.
1986.
Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line.
Mol. Cell. Biol.
6:4133-4135[Abstract/Free Full Text].
|
| 30.
|
Murray, M. J., and D. Kabat.
1979.
Genetic and sialyation sources of heterogeneity of the murine leukemia virus membrane envelope glycoproteins gp69/71.
J. Biol. Chem.
254:1340-1348[Free Full Text].
|
| 31.
|
Omer, C. A.,
R. Pogue-Geile,
R. Guntaka,
K. A. Staskus, and A. J. Faras.
1983.
Involvement of directly repeated sequences in the generation of deletions of the avian sarcoma virus src gene.
J. Virol.
47:380-382[Abstract/Free Full Text].
|
| 32.
|
Ostertag, W.,
C. Stocking,
G. R. Johnson,
N. Kluge,
R. Kollek,
T. Franz, and N. Hess.
1987.
Transforming genes and target cells of murine spleen focus-forming viruses.
Adv. Cancer Res.
48:193-355[Medline].
|
| 33.
|
Parthasarathi, S.,
A. Varela-Echavarria,
Y. Ron,
B. D. Preston, and J. P. Dougherty.
1995.
Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.
J. Virol.
69:7991-8000[Abstract].
|
| 34.
|
Pathak, T., and H. Temin.
1990.
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations.
Proc. Natl. Acad. Sci. USA
87:6019-6023[Abstract/Free Full Text].
|
| 35.
|
Pathak, V., and H. Temin.
1990.
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions.
Proc. Natl. Acad. Sci. USA
87:6024-6028[Abstract/Free Full Text].
|
| 36.
|
Pinter, A., and W. J. Honnen.
1985.
The mature form of the Friend spleen focus-forming virus envelope protein, gp65, is efficiently secreted from cells.
Virology
143:646-650[Medline].
|
| 37.
|
Pulsinelli, G., and H. Temin.
1991.
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer.
J. Virol.
65:4786-4797[Abstract/Free Full Text].
|
| 38.
|
Purcell, D.,
C. Broscius,
E. Vanin,
C. Buckler,
A. Nienhuis, and M. Martin.
1996.
An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer.
J. Virol.
70:887-897[Abstract].
|
| 39.
|
Rodenhiser, D.,
P. Chakraborty,
J. Andrews,
P. Ainsworth,
D. Mancini,
E. Lopes, and S. Singh.
1996.
Heterogenous point mutations in the BRCA1 breast cancer susceptibility gene occur in high frequency at the site of homonucleotide tracts, short repeats and methylatable CpG/CpNpG motifs.
Oncogene
12:2623-2629[Medline].
|
| 40.
|
Ruscetti, S., and L. Wolff.
1984.
Spleen focus-forming virus: relationship of an altered envelope gene to the development of a rapid erythroleukemia.
Curr. Top. Microbiol. Immunol.
112:21-44[Medline].
|
| 41.
|
Ruscetti, S. K.,
L. Davis,
J. Feild, and A. Oliff.
1981.
Friend murine leukemia virus-induced leukemia is associated with formation of mink cell focus-inducing viruses and is blocked in mice expressing endogenous mink cell focus-inducing xenotropic viral envelope genes.
J. Exp. Med.
154:907-920[Abstract/Free Full Text].
|
| 42.
|
Ruscetti, S. K.,
N. J. Janesch,
A. Chakraborti,
S. T. Sawyer, and D. W. Hankins.
1990.
Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line.
J. Virol.
63:1057-1062.
|
| 43.
|
Ruta, M.,
S. Clarke,
B. Boswell, and D. Kabat.
1982.
Heterogeneous metabolism and subcellular localization of a potentially leukemogenic membrane glycoprotein encoded by Friend erythroleukemia virus.
J. Biol. Chem.
257:126-134[Free Full Text].
|
| 44.
|
Ruta, M., and D. Kabat.
1980.
Plasma membrane glycoproteins encoded by Rauscher and Friend spleen focus-forming viruses.
J. Virol.
35:844-853[Abstract/Free Full Text].
|
| 45.
|
Sanchez, G.,
X. Xu,
J.-C. Chermann, and I. Hirsch.
1997.
Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals.
J. Virol.
71:2233-2240[Abstract].
|
| 46.
|
Showers, M.,
J. DeMartino,
Y. Saito, and A. D'Andrea.
1993.
Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line.
Mol. Cell. Biol.
13:739-748[Abstract/Free Full Text].
|
| 47.
|
Srinivas, R.,
D. Kilpatrick,
S. Tucker,
Z. Rui, and R. Compans.
1991.
The hydrophobic membrane-spanning sequences of the gp52 glycoprotein are required for the pathogenicity of spleen focus-forming virus.
J. Virol.
65:5272-5280[Abstract/Free Full Text].
|
| 48.
|
Steinhaure, D., and J. Holland.
1987.
Rapid evolution of RNA viruses.
Annu. Rev. Microbiol.
41:409-433[Medline].
|
| 49.
|
Swain, A., and J. Coffin.
1992.
Mechanism of transduction by retroviruses.
Science
255:841-845[Abstract/Free Full Text].
|
| 50.
|
Teich, N.,
J. Wycke,
T. Mak,
A. Bernstein, and W. Hardy.
1982.
Pathogenesis of retrovirus-induced disease, p. 785-998.
In
R. Weiss, et al. (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 51.
|
Temin, H.
1993.
Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation.
Proc. Natl. Acad. Sci. USA
90:6900-6903[Abstract/Free Full Text].
|
| 52.
|
Varela-Echavarria, A.,
C. Prorock,
Y. Ron, and J. Dougherty.
1993.
High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector.
J. Virol.
67:6357-6364[Abstract/Free Full Text].
|
| 53.
|
Voynow, S., and J. Coffin.
1985.
Evolutionary variants of Rous sarcoma virus: large deletion mutants do not result from homologous recombination.
J. Virol.
55:67-78[Abstract/Free Full Text].
|
| 54.
|
Watanabe, N.,
M. Nishi,
Y. Ikawa, and H. Amanuma.
1991.
Conversion of Friend mink cell focus-forming virus to Friend spleen focus-forming virus by modification of the 3' half of the env gene.
J. Virol.
65:132-137[Abstract/Free Full Text].
|
| 55.
|
Watanabe, N.,
M. Nishi,
Y. Ikawa, and H. Amanuma.
1990.
A deletion in the Friend spleen focus-forming virus env gene is necessary for its product (gp55) to be leukemogenic.
J. Virol.
64:2678-2686[Abstract/Free Full Text].
|
| 56.
|
Wolff, L., and S. Ruscetti.
1985.
Malignant transformation of erythroid cells in vivo by introduction of a non-replicating retrovirus vector.
Science
228:1549-1552[Abstract/Free Full Text].
|
| 57.
|
Wolff, L.,
E. Scolnick, and S. Ruscetti.
1983.
Envelope gene of the Friend spleen focus-forming virus: deletion and insertions in the 3' gp70/p15E-encoding region have resulted in unique features in the primary structure of its protein product.
Proc. Natl. Acad. Sci. USA
80:4718-4722[Abstract/Free Full Text].
|
| 58.
|
Zhang, J., and H. Temin.
1993.
3' junction of oncogene-virus sequences and the mechanisms for formation of highly oncogenic retroviruses.
J. Virol.
67:1747-1751[Free Full Text].
|
| 59.
|
Zon, L.,
J. Moreau,
J. Koo,
B. Mathey-Prevot, and A. D'Andrea.
1992.
The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein.
Mol. Cell. Biol.
12:2949-2957[Abstract/Free Full Text].
|
J Virol, May 1998, p. 3742-3750, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Shi, Y., Roy-Burman, P.
(2000). A Novel Truncated env Gene Isolated from a Feline Leukemia Virus-Induced Thymic Lymphosarcoma. J. Virol.
74: 1451-1456
[Abstract]
[Full Text]